Bronchiectasis and NTM Establishes Care Center Network with 33 Sites
Twenty-seven health centers have been added to the new Bronchiectasis and NTM Care Center Network, along with six clinical associate center sites.
Twenty-seven health centers have been added to the new Bronchiectasis and NTM Care Center Network, along with six clinical associate center sites.
Twenty-seven health centers have been added to the new Bronchiectasis and NTM Care Center Network, along with six clinical associate center sites.
Read MoreTen years after Leonard Nimoy’s death from COPD a documentary covering the actor’s struggle with the disease is being re-released via a partnership by The COPD Foundation, The Nimoy Knight Foundation, and Health Point Productions.
Read MoreThe Bronchiectasis and NTM Association will continued the organization’s growth as a leader in advancing care, research, and awareness of bronchiectasis and NTM lung disease.
Read MoreThe CDC’s National Center for Health Statistics released its “Deaths: Leading Causes for 2022” final report, ranking the 10 leading causes of death.
Read MoreNew commentary highlights the need for patient-inspired frameworks to guide COPD therapy development.
Read MoreNovember is COPD Awareness Month and the COPD Foundation is working to better inform the community about the disease by debunking common myths.
Read MoreHealthcare organizations are urging Congress to pass the SOAR Act to ensure Medicare patients have access to the supplemental oxygen they need for improved health and mobility.
Read MoreThe COPD Foundation has partnered with Clean Air Dynamics to emphasize the importance of clean air for managing chronic lung diseases and enhancing patient quality of life.
Read MoreWorld Bronchiectasis Day (July 1) was established in 2022 to raise awareness of bronchiectasis and its increased prevalence in many countries.
Read MoreA new project aimed at increasing the use of digital endpoints in clinical trials is being spearheaded by the COPD Foundation in collaboration with the Digital Medicine Society.
Read MoreThe COPD Foundation Nebulizer Consortium’s statement provides recommendations for preventing the spread of respiratory illnesses in healthcare settings and home environments.
Read MoreThe Supplemental Oxygen Access Reform Act of 2024, designed to ease access to supplemental oxygen for Medicare beneficiaries, was introduced in the US House of Representatives by a bipartisan group of members of Congress.
Read MoreThe patient care network will facilitate access to specialized care and support for individuals with bronchiectasis and NTM lung disease.
Read MoreThe COPD Foundation and Kivo Health, which provides telehealth pulmonary rehabilitation for individuals with COPD, have partnered to improve access to virtual pulmonary rehab.
Read MoreA survey found individuals with COPD were overwhelmingly positive about the prospect of taking an antiviral nasal spray throughout the winter season to prevent COPD flare-ups.
Read MoreThe COPD Foundation has promoted Ruth Tal-Singer, PhD, to president & CEO. Dr. Tal-Singer has served as the organization’s president & chief scientific officer since 2020.
Read MoreThe COPD Foundation introduced PIVOT, Patient Inspired Validation of Outcome Tools, — a patient-centric framework that will support the coordination of activities for developing, validating, and qualifying biomarkers and clinical outcome assessments that evaluate the benefit of treatment approaches in COPD, bronchiectasis, and NTM lung disease.
Read MoreENA Respiratory and the COPD Foundation are partnering to develop an antiviral nasal spray to prevent and reduce incidence and severity of respiratory viral infections in people with chronic lung diseases like COPD.
Read MoreThe European Lung Fdn and COPD Fdn are surveying patients over whether the term “COPD crisis” would better describe their exacerbations.
Read MoreA joint statement from the ATS, ALA, Chest, and COPD Foundation emphasizes the importance of wearing masks and face coverings to prevent transmission of COVID-19.
Read MorePRAXIS is an interactive online community designed to support COPD caregivers and administrators to prevent and reduce hospital admissions and readmissions by improving care across the COPD care continuum.
Read MoreSponsored by AstraZeneca, COPD360 will combine patient-reported outcomes, clinical data, and EMR into one of the largest COPD research networks ever assembled.
Read MoreCompared to COPD, asthma, or cystic fibrosis, Alpha-1 antitrypsin deficiency lung disease is not well known, but dedicated researchers and RTs continue to support patients and work towards finding new treatment options.
Read MorePatients with COPD may need more education and better dialogue with their physicians to effectively manage the disease and potentially life-threatening exacerbations, according to the national COPE (Chronic Obstructive Pulmonary Experience) Survey released by the COPD Foundation.
Read More